<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>How to Keep the Weight Off After Stopping GLP-1: A Physician's Six-Step Protocol — Élan Clinic</title>
  <meta name="description" content="Weight regain after Ozempic or Wegovy is common — but not inevitable. An Élan Clinic physician outlines the six-step clinical protocol that gives you the best chance of keeping the weight off for good." />
  <link rel="canonical" href="https://elan.clinic/blog/how-to-keep-weight-off-after-glp1.html" />
  <link rel="icon" type="image/svg+xml" href="/favicon.svg" />

  <!-- Open Graph -->
  <meta property="og:type" content="article" />
  <meta property="og:url" content="https://elan.clinic/blog/how-to-keep-weight-off-after-glp1.html" />
  <meta property="og:title" content="How to Keep the Weight Off After Stopping GLP-1: A Physician's Six-Step Protocol" />
  <meta property="og:description" content="Weight regain after Ozempic or Wegovy is common — but not inevitable. An Élan Clinic physician outlines the six-step clinical protocol that gives you the best chance of keeping the weight off for good." />
  <meta property="og:locale" content="en_GB" />
  <meta property="article:published_time" content="2026-02-28" />
  <meta property="article:author" content="Dr. Ingmar Lindström" />

  <!-- Schema.org MedicalWebPage + FAQ + BreadcrumbList -->
  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "MedicalWebPage",
    "name": "How to Keep the Weight Off After Stopping GLP-1: A Physician's Six-Step Protocol",
    "headline": "How to Keep the Weight Off After Stopping GLP-1: A Physician's Six-Step Protocol",
    "url": "https://elan.clinic/blog/how-to-keep-weight-off-after-glp1.html",
    "datePublished": "2026-02-28",
    "inLanguage": "en",
    "description": "Weight regain after Ozempic or Wegovy is common — but not inevitable. An Élan Clinic physician outlines the six-step clinical protocol that gives you the best chance of keeping the weight off for good.",
    "about": {
      "@type": "MedicalCondition",
      "name": "Obesity"
    },
    "medicalAudience": {
      "@type": "MedicalAudience",
      "audienceType": "Patient"
    },
    "author": {
      "@type": "Person",
      "name": "Dr. Ingmar Lindström",
      "jobTitle": "Physician",
      "worksFor": {
        "@type": "MedicalClinic",
        "name": "Élan Clinic",
        "url": "https://elan.clinic"
      }
    },
    "publisher": {
      "@type": "MedicalClinic",
      "name": "Élan Clinic",
      "url": "https://elan.clinic",
      "logo": "https://elan.clinic/favicon.svg",
      "telephone": "+37252999399",
      "address": {
        "@type": "PostalAddress",
        "streetAddress": "Sepapaja 12/1",
        "addressLocality": "Tallinn",
        "postalCode": "11415",
        "addressCountry": "EE"
      }
    },
    "mainEntityOfPage": {
      "@type": "WebPage",
      "@id": "https://elan.clinic/blog/how-to-keep-weight-off-after-glp1.html"
    },
    "citation": [
      {
        "@type": "ScholarlyArticle",
        "name": "Weight regain after discontinuation of GLP-1 receptor agonists: a systematic review and meta-analysis",
        "author": "West et al.",
        "isPartOf": { "@type": "Periodical", "name": "BMJ" },
        "identifier": "BMJ 2026;392:e085304",
        "datePublished": "2026"
      },
      {
        "@type": "ScholarlyArticle",
        "name": "STEP 1 trial extension: weight regain after semaglutide discontinuation",
        "isPartOf": { "@type": "Periodical", "name": "PubMed" },
        "identifier": "PubMed 35441470",
        "datePublished": "2022"
      }
    ]
  }
  </script>

  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "FAQPage",
    "mainEntity": [
      {
        "@type": "Question",
        "name": "How much weight do people typically regain after stopping GLP-1 medications?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "According to a 2026 BMJ meta-analysis (West et al., BMJ 2026;392:e085304), people regain an average of 0.4 kg per month after stopping GLP-1 therapy, with most returning to near-baseline weight within about 1.7 years. However, 77% of people retain some of their weight loss at two years — meaning the outcome is not predetermined. What you do in the first 20 weeks matters enormously."
        }
      },
      {
        "@type": "Question",
        "name": "What is the most important thing to do immediately after stopping Ozempic or Wegovy?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "Prioritise protein intake and resistance training simultaneously. GLP-1 medications cause roughly 25–30% of weight loss to come from lean muscle mass. As hunger returns, the body preferentially rebuilds fat rather than muscle unless you actively preserve it through high protein intake (minimum 1.6 g per kilogram of body weight daily) and strength training at least twice a week."
        }
      },
      {
        "@type": "Question",
        "name": "When should someone consider restarting GLP-1 therapy?",
        "acceptedAnswer": {
          "@type": "Answer",
          "text": "If weight regain exceeds 5% of your lowest achieved weight despite following a structured maintenance protocol — high protein intake, resistance training, structured meals, weekly monitoring — it is medically appropriate to discuss restarting with your physician. Obesity is a chronic condition, and long-term or intermittent GLP-1 use is supported by evidence. An Élan Clinic consultation can help evaluate whether restart is the right move for you."
        }
      }
    ]
  }
  </script>

  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
      {
        "@type": "ListItem",
        "position": 1,
        "name": "Home",
        "item": "https://elan.clinic/"
      },
      {
        "@type": "ListItem",
        "position": 2,
        "name": "Articles",
        "item": "https://elan.clinic/blog.html"
      },
      {
        "@type": "ListItem",
        "position": 3,
        "name": "How to Keep the Weight Off After Stopping GLP-1",
        "item": "https://elan.clinic/blog/how-to-keep-weight-off-after-glp1.html"
      }
    ]
  }
  </script>

  <!-- Google Fonts -->
  <link rel="preconnect" href="https://fonts.googleapis.com" />
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin />
  <link href="https://fonts.googleapis.com/css2?family=Playfair+Display:ital,wght@0,400;0,500;0,600;0,700;1,400;1,500&family=Inter:wght@300;400;500;600&display=swap" rel="stylesheet" />

  <style>
    /* ─── Reset & Base ─────────────────────────────────────────────── */
    *, *::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }

    html { scroll-behavior: smooth; font-size: 16px; }

    body {
      font-family: 'Inter', sans-serif;
      background-color: #0D1B2A;
      color: rgba(232, 228, 222, 0.55);
      line-height: 1.7;
      -webkit-font-smoothing: antialiased;
    }

    h1, h2, h3, h4 {
      font-family: 'Playfair Display', serif;
      color: #E8E4DE;
      line-height: 1.2;
      font-weight: 500;
    }

    a { color: #C5A55A; text-decoration: none; }
    a:hover { text-decoration: underline; }

    /* ─── Layout ───────────────────────────────────────────────────── */
    .container {
      width: 100%;
      max-width: 1200px;
      margin: 0 auto;
      padding: 0 24px;
    }

    /* ─── Gold Utilities ───────────────────────────────────────────── */
    .label {
      display: inline-block;
      font-family: 'Inter', sans-serif;
      font-size: 0.7rem;
      font-weight: 600;
      letter-spacing: 0.18em;
      text-transform: uppercase;
      color: #C5A55A;
      margin-bottom: 20px;
    }

    .gold-line {
      width: 48px;
      height: 2px;
      background: #C5A55A;
      margin: 28px 0;
    }

    /* ─── Nav ──────────────────────────────────────────────────────── */
    .nav {
      position: fixed;
      top: 0;
      left: 0;
      right: 0;
      z-index: 100;
      padding: 20px 24px;
      display: flex;
      align-items: center;
      justify-content: space-between;
      background: rgba(13, 27, 42, 0.92);
      backdrop-filter: blur(12px);
      border-bottom: 1px solid rgba(197, 165, 90, 0.12);
    }

    .nav__logo {
      font-family: 'Playfair Display', serif;
      font-size: 1.25rem;
      color: #E8E4DE;
      letter-spacing: 0.06em;
      text-decoration: none;
    }

    .nav__logo span { color: #C5A55A; }

    .nav__links {
      display: flex;
      align-items: center;
      gap: 32px;
      list-style: none;
    }

    .nav__links a {
      font-size: 0.78rem;
      font-weight: 500;
      letter-spacing: 0.1em;
      text-transform: uppercase;
      color: rgba(232, 228, 222, 0.65);
      text-decoration: none;
      transition: color 0.2s;
    }

    .nav__links a:hover,
    .nav__links a.active { color: #C5A55A; }

    /* ─── Breadcrumb ───────────────────────────────────────────────── */
    .breadcrumb {
      padding: 120px 0 0;
      background-color: #0D1B2A;
    }

    .breadcrumb__inner {
      display: flex;
      align-items: center;
      gap: 8px;
      flex-wrap: wrap;
    }

    .breadcrumb__item {
      font-size: 0.75rem;
      font-weight: 500;
      letter-spacing: 0.08em;
      color: rgba(232, 228, 222, 0.4);
      text-transform: uppercase;
    }

    .breadcrumb__item a {
      color: rgba(232, 228, 222, 0.4);
      text-decoration: none;
      transition: color 0.2s;
    }

    .breadcrumb__item a:hover {
      color: #C5A55A;
      text-decoration: none;
    }

    .breadcrumb__sep {
      font-size: 0.7rem;
      color: rgba(197, 165, 90, 0.4);
    }

    .breadcrumb__item--current {
      color: #C5A55A;
    }

    /* ─── Article Header ───────────────────────────────────────────── */
    .article-header {
      padding: 48px 0 64px;
      background-color: #0D1B2A;
      position: relative;
      overflow: hidden;
    }

    .article-header::before {
      content: '';
      position: absolute;
      top: -100px;
      right: -150px;
      width: 500px;
      height: 500px;
      background: radial-gradient(circle, rgba(197,165,90,0.05) 0%, transparent 70%);
      pointer-events: none;
    }

    .article-header__content {
      max-width: 780px;
    }

    .article-header h1 {
      font-size: clamp(2rem, 4.5vw, 3.2rem);
      line-height: 1.15;
      margin-bottom: 28px;
    }

    .article-meta {
      display: flex;
      align-items: center;
      flex-wrap: wrap;
      gap: 24px;
      padding-top: 24px;
      border-top: 1px solid rgba(197, 165, 90, 0.15);
    }

    .article-meta__item {
      display: flex;
      align-items: center;
      gap: 8px;
      font-size: 0.8rem;
      color: rgba(232, 228, 222, 0.5);
    }

    .article-meta__item strong {
      color: rgba(232, 228, 222, 0.75);
      font-weight: 500;
    }

    .article-meta__dot {
      width: 3px;
      height: 3px;
      border-radius: 50%;
      background: rgba(197, 165, 90, 0.4);
    }

    /* ─── Article Body ─────────────────────────────────────────────── */
    .article-body {
      padding: 0 0 100px;
      background-color: #0D1B2A;
    }

    .article-body__inner {
      max-width: 780px;
    }

    .article-body p {
      font-size: 1.05rem;
      color: rgba(232, 228, 222, 0.72);
      line-height: 1.85;
      margin-bottom: 28px;
    }

    .article-body h2 {
      font-size: clamp(1.5rem, 2.5vw, 2rem);
      margin: 56px 0 20px;
      color: #E8E4DE;
    }

    .article-body h3 {
      font-size: clamp(1.1rem, 2vw, 1.35rem);
      margin: 40px 0 16px;
      color: #E8E4DE;
    }

    .article-body strong {
      color: rgba(232, 228, 222, 0.9);
      font-weight: 600;
    }

    .article-body em {
      color: rgba(232, 228, 222, 0.65);
      font-style: italic;
    }

    .article-body hr {
      border: none;
      height: 1px;
      background: rgba(197, 165, 90, 0.15);
      margin: 48px 0;
    }

    /* ─── Pull Quote ───────────────────────────────────────────────── */
    .pull-quote {
      border-left: 3px solid #C5A55A;
      padding: 20px 32px;
      margin: 40px 0;
      background: rgba(197, 165, 90, 0.04);
    }

    .pull-quote p {
      font-family: 'Playfair Display', serif;
      font-size: 1.2rem !important;
      font-style: italic;
      color: rgba(232, 228, 222, 0.82) !important;
      line-height: 1.6 !important;
      margin: 0 !important;
    }

    /* ─── Key Stat ─────────────────────────────────────────────────── */
    .key-stat {
      background: #111D2E;
      border: 1px solid rgba(197, 165, 90, 0.18);
      padding: 32px 36px;
      margin: 40px 0;
    }

    .key-stat__number {
      font-family: 'Playfair Display', serif;
      font-size: 3rem;
      color: #C5A55A;
      line-height: 1;
      margin-bottom: 8px;
    }

    .key-stat__label {
      font-size: 0.88rem;
      color: rgba(232, 228, 222, 0.6);
      line-height: 1.5;
    }

    /* ─── Step Box ─────────────────────────────────────────────────── */
    .step-box {
      background: #111D2E;
      border: 1px solid rgba(197, 165, 90, 0.15);
      border-left: 3px solid #C5A55A;
      padding: 28px 32px;
      margin: 40px 0;
    }

    .step-box__number {
      font-family: 'Playfair Display', serif;
      font-size: 0.75rem;
      font-weight: 600;
      letter-spacing: 0.18em;
      text-transform: uppercase;
      color: #C5A55A;
      margin-bottom: 8px;
    }

    .step-box__title {
      font-family: 'Playfair Display', serif;
      font-size: 1.15rem;
      color: #E8E4DE;
      margin-bottom: 12px;
    }

    .step-box p {
      font-size: 0.92rem !important;
      color: rgba(232, 228, 222, 0.65) !important;
      line-height: 1.7 !important;
      margin: 0 !important;
    }

    /* ─── Article Sources ──────────────────────────────────────────── */
    .article-sources {
      margin-top: 60px;
      padding-top: 32px;
      border-top: 1px solid rgba(197, 165, 90, 0.12);
    }

    .article-sources p {
      font-size: 0.82rem !important;
      color: rgba(232, 228, 222, 0.38) !important;
      line-height: 1.6 !important;
      margin-bottom: 8px !important;
    }

    .article-sources .sources-label {
      font-size: 0.7rem;
      font-weight: 600;
      letter-spacing: 0.15em;
      text-transform: uppercase;
      color: #C5A55A;
      margin-bottom: 16px;
      display: block;
    }

    /* ─── Back Link ────────────────────────────────────────────────── */
    .back-link {
      display: inline-flex;
      align-items: center;
      gap: 8px;
      font-size: 0.78rem;
      font-weight: 600;
      letter-spacing: 0.1em;
      text-transform: uppercase;
      color: rgba(232, 228, 222, 0.5);
      text-decoration: none;
      transition: color 0.2s, gap 0.2s;
      margin-bottom: 60px;
    }

    .back-link:hover {
      color: #C5A55A;
      gap: 12px;
      text-decoration: none;
    }

    /* ─── Footer CTA ───────────────────────────────────────────────── */
    .footer-cta {
      background-color: #111D2E;
      border-top: 1px solid rgba(197, 165, 90, 0.12);
      text-align: center;
      padding: 100px 24px;
    }

    .footer-cta h2 {
      max-width: 620px;
      margin: 0 auto 24px;
      font-size: clamp(1.6rem, 3vw, 2.2rem);
    }

    .footer-cta__sub {
      max-width: 480px;
      margin: 0 auto 40px;
      font-size: 0.95rem;
    }

    /* ─── Button ───────────────────────────────────────────────────── */
    .btn {
      display: inline-block;
      padding: 16px 36px;
      font-family: 'Inter', sans-serif;
      font-size: 0.85rem;
      font-weight: 600;
      letter-spacing: 0.1em;
      text-transform: uppercase;
      border: 1.5px solid #C5A55A;
      color: #C5A55A;
      background: transparent;
      cursor: pointer;
      transition: background 0.2s, color 0.2s;
      text-decoration: none;
    }

    .btn:hover {
      background: #C5A55A;
      color: #0D1B2A;
      text-decoration: none;
    }

    .btn--filled {
      background: #C5A55A;
      color: #0D1B2A;
    }

    .btn--filled:hover {
      background: #d4b56a;
      color: #0D1B2A;
    }

    /* ─── Footer Legal ─────────────────────────────────────────────── */
    .footer-legal {
      background-color: #0D1B2A;
      border-top: 1px solid rgba(197, 165, 90, 0.08);
      padding: 40px 24px;
    }

    .footer-legal__inner {
      max-width: 1200px;
      margin: 0 auto;
      display: flex;
      flex-direction: column;
      gap: 8px;
    }

    .footer-legal p {
      font-size: 0.75rem;
      color: rgba(232, 228, 222, 0.3);
      line-height: 1.6;
    }

    /* ─── Responsive ───────────────────────────────────────────────── */
    @media (max-width: 768px) {
      .nav__links {
        gap: 16px;
      }

      .nav__links a {
        font-size: 0.72rem;
      }

      .breadcrumb {
        padding-top: 100px;
      }

      .article-header {
        padding: 32px 0 48px;
      }

      .article-body p {
        font-size: 0.98rem;
      }

      .key-stat__number {
        font-size: 2.4rem;
      }

      .pull-quote {
        padding: 16px 20px;
      }

      .step-box {
        padding: 20px 20px;
      }
    }
  </style>
</head>
<body>

  <!-- ─── Navigation ────────────────────────────────────────────── -->
  <nav class="nav">
    <a href="/" class="nav__logo">Élan<span>.</span></a>
    <ul class="nav__links">
      <li><a href="/">Home</a></li>
      <li><a href="/blog.html" class="active">Articles</a></li>
      <li><a href="/faq.html">FAQ</a></li>
      <li style="margin-left:8px;border-left:1px solid rgba(197,165,90,0.25);padding-left:16px;display:flex;gap:12px;"><a href="/et.html" style="font-size:0.7rem;">EST</a> <a href="/ukk.html" style="font-size:0.7rem;">FIN</a> <a href="/voprosy.html" style="font-size:0.7rem;">RUS</a></li>
      <li><a href="/#consultation" class="btn" style="padding: 10px 20px; font-size: 0.72rem;">Book a Consultation</a></li>
    </ul>
  </nav>

  <!-- ─── Breadcrumb ────────────────────────────────────────────── -->
  <div class="breadcrumb">
    <div class="container">
      <nav class="breadcrumb__inner" aria-label="Breadcrumb">
        <span class="breadcrumb__item"><a href="/">Home</a></span>
        <span class="breadcrumb__sep">›</span>
        <span class="breadcrumb__item"><a href="/blog.html">Articles</a></span>
        <span class="breadcrumb__sep">›</span>
        <span class="breadcrumb__item breadcrumb__item--current">How to Keep the Weight Off After Stopping GLP-1</span>
      </nav>
    </div>
  </div>

  <!-- ─── Article Header ───────────────────────────────────────── -->
  <header class="article-header">
    <div class="container">
      <div class="article-header__content">
        <span class="label">GLP-1 Medications · Weight Maintenance</span>
        <h1>How to Keep the Weight Off After Stopping GLP-1: A Physician's Six-Step Protocol</h1>
        <div class="article-meta">
          <div class="article-meta__item">
            <strong>Dr. Ingmar Lindström</strong>
          </div>
          <div class="article-meta__dot"></div>
          <div class="article-meta__item">
            <time datetime="2026-02-28">February 28, 2026</time>
          </div>
          <div class="article-meta__dot"></div>
          <div class="article-meta__item">
            9 min read
          </div>
        </div>
      </div>
    </div>
  </header>

  <!-- ─── Article Body ──────────────────────────────────────────── -->
  <main class="article-body">
    <div class="container">
      <div class="article-body__inner">

        <p>
          Here is a number that should be part of every conversation about GLP-1 medications, but rarely is: 0.4 kilograms per month.
        </p>

        <p>
          That is the average regain rate after stopping Ozempic or Wegovy, according to a 2026 BMJ meta-analysis that tracked thousands of people across multiple trials (West et al., BMJ 2026;392:e085304). At that pace, most of the weight that took months — sometimes years — of injections to lose comes back within about 18 months.
        </p>

        <p>
          I am not telling you this to frighten you. I am telling you because the Ozempic Aftermath — what happens after the prescription ends — is something almost nobody talks about clearly, and you deserve the honest picture before you need it.
        </p>

        <div class="key-stat">
          <div class="key-stat__number">77%</div>
          <div class="key-stat__label">of people retain <em>some</em> of their weight loss at two years post-treatment — meaning the outcome is not predetermined. What you do in the first 20 weeks matters enormously. (EPIC Research, September 2025)</div>
        </div>

        <p>
          This is the six-step protocol we use at Élan Clinic for people who are planning to stop, or who have recently stopped, GLP-1 therapy. It is practical, evidence-based, and designed for real life — not a medical textbook.
        </p>

        <hr />

        <h2>Why the first 12 weeks are critical</h2>

        <p>
          When you stop a GLP-1 medication, your body does not gently return to its previous state. It snaps back. The drug was suppressing ghrelin (your hunger hormone), slowing gastric emptying, and sending satiety signals to your hypothalamus. When that pharmacological support is removed, all three systems reactivate — and they do not always recalibrate in a measured, polite way.
        </p>

        <p>
          The BMJ data shows regain typically begins around eight weeks after the final injection and accelerates through a 20-week window. This is the period when habits either carry the load or do not.
        </p>

        <div class="pull-quote">
          <p>GLP-1 was the scaffold. You have now removed it. The question is whether the building can stand on its own.</p>
        </div>

        <p>
          The six steps below are how you build that structure before the scaffold comes down — and how you reinforce it afterward.
        </p>

        <hr />

        <h2>The Six-Step Protocol</h2>

        <div class="step-box">
          <div class="step-box__number">Step 1</div>
          <div class="step-box__title">Stop gradually, not overnight</div>
          <p>If you have any say in how your treatment ends, do not stop abruptly. A structured taper over four to eight weeks significantly reduces the sharpness of the appetite rebound — because your brain gets time to adjust, rather than experiencing a sudden total withdrawal of the GLP-1 signal. The standard approach is to step down to half your usual dose for two to four weeks, then to a quarter dose, then stop. A full tapering protocol is covered separately in our article on stopping semaglutide correctly.</p>
        </div>

        <div class="step-box">
          <div class="step-box__number">Step 2</div>
          <div class="step-box__title">Protein, and then more protein</div>
          <p>GLP-1 medications are effective. They are also imprecise. When you lose weight on semaglutide or tirzepatide, roughly 25 to 30% of that weight loss comes from lean muscle mass rather than fat (STEP 1 extension trial, PubMed 35441470). The evidence supports a minimum of 1.6 grams per kilogram of body weight per day to preserve muscle mass. In practice, that means building three meals per day around a 30–40 gram protein anchor: eggs, cottage cheese, chicken, legumes, Greek yoghurt.</p>
        </div>

        <div class="step-box">
          <div class="step-box__number">Step 3</div>
          <div class="step-box__title">Resistance training, twice a week, non-negotiable</div>
          <p>A 2024 trial published in <em>Frontiers in Endocrinology</em> compared outcomes for people stopping GLP-1 therapy. Those who continued structured resistance training maintained significantly more of their weight loss at 12 months than those who did not. Cardio has benefits, but when the primary goal is weight maintenance, resistance training wins — because it directly addresses the muscle loss problem. Twice a week is the evidence-supported floor. Three times is better.</p>
        </div>

        <div class="step-box">
          <div class="step-box__number">Step 4</div>
          <div class="step-box__title">Manage hunger actively</div>
          <p>This is the step that catches people off guard. The practical tools for managing hunger without pharmacological support: structured meals every four to five hours (to prevent ghrelin spikes); soluble fibre at every meal (slows gastric emptying); and adequate sleep — seven to nine hours. Sleep deprivation measurably increases ghrelin and decreases leptin. If your sleep is poor, fixing it will do more for your hunger management than almost anything else on this list.</p>
        </div>

        <div class="step-box">
          <div class="step-box__number">Step 5</div>
          <div class="step-box__title">Monitor your weight weekly, not daily</div>
          <p>Daily weighing creates noise. Weight fluctuates by one to two kilograms naturally across a single day. Weekly weigh-ins — same time, same conditions (morning, after using the bathroom, before eating) — give you trend data. Establish a personal trigger point now: if your weight increases by two kilograms above your maintenance baseline, activate an intensified protocol. Two kilograms is correctable without drama. Ten kilograms is a different conversation.</p>
        </div>

        <div class="step-box">
          <div class="step-box__number">Step 6</div>
          <div class="step-box__title">The environment does not fix itself</div>
          <p>GLP-1 medications suppressed appetite. They did not change your kitchen, your habits, your relationship with food, or the environmental triggers that influenced your eating in the first place. That work still needs to happen — and now you have to do it without pharmaceutical support. A food environment audit is worth doing once: go through your kitchen and remove the high-calorie, low-satiety foods that you can eat without thinking. Friction works.</p>
        </div>

        <hr />

        <h2>When to consider continued treatment</h2>

        <p>
          Here is something worth saying plainly: obesity is a chronic condition. For some people, the most medically appropriate long-term management includes continued GLP-1 therapy — intermittently, at a maintenance dose, or indefinitely. This is not a failure. It is how we manage most chronic conditions.
        </p>

        <p>
          If you have followed this protocol conscientiously for three to six months and weight regain continues, the right conversation to have is not "what am I doing wrong?" It is "is ongoing medical treatment appropriate for me?" At Élan Clinic, we can help you evaluate that question without judgment.
        </p>

        <hr />

        <h2>The bottom line</h2>

        <p>
          Weight management is an infinite game — not a finite one you win once and walk away from. GLP-1 medications give you a significant advantage in that game for the duration of treatment. What happens after depends on the habits you build while that advantage is active.
        </p>

        <p>
          The biology will work against you for roughly 20 weeks. The protocol above is designed to work against the biology. Use both the time and the tool you have been given well.
        </p>

        <p>
          Also worth reading: <a href="/blog/how-to-stop-semaglutide-safely.html">How to Stop Semaglutide the Right Way: A Step-Down Protocol →</a>
        </p>

        <!-- ─── Sources ─────────────────────────────────────────── -->
        <div class="article-sources">
          <span class="sources-label">Sources</span>
          <p>West et al. "Weight regain after discontinuation of GLP-1 receptor agonists: a systematic review and meta-analysis." <em>BMJ</em> 2026;392:e085304.</p>
          <p>STEP 1 extension trial. PubMed 35441470.</p>
          <p>EPIC Research, September 2025. Post-discontinuation weight retention data.</p>
          <p>Frontiers in Endocrinology: exercise and GLP-1 maintenance trial, 2024.</p>
          <p><em>This article reflects general clinical guidance and is not a substitute for personalised medical advice. Please consult your physician before making changes to your treatment plan.</em></p>
        </div>

        <!-- ─── Back Link ──────────────────────────────────────── -->
        <a href="/blog.html" class="back-link">← Back to Articles</a>

      </div>
    </div>
  </main>

  <!-- ─── Footer CTA ────────────────────────────────────────────── -->
  <section class="footer-cta">
    <span class="label">Consultation</span>
    <h2>Ready to Build Your Maintenance Plan?</h2>
    <p class="footer-cta__sub">
      A 45-minute consultation where we assess your situation and build a personalised protocol for long-term weight maintenance — before, during, and after GLP-1 therapy.
    </p>
    <a href="tel:+37252999399" class="btn btn--filled">Call +372 52 99939</a>
  </section>

  <!-- ─── Footer Legal ──────────────────────────────────────────── -->
  <footer class="footer-legal">
    <div class="footer-legal__inner">
      <p>© 2026 Élan Clinic · Elan Clinic OÜ · Reg 17338832 · Medical licence L07470 · Sepapaja 12/1, Tallinn 11415</p>
      <p>This article is for informational purposes only and does not constitute medical advice. Consult your physician before changing any medication or health programme.</p>
    </div>
  </footer>

</body>
</html>
